PDL BioPharma Announces Appointment of Edward A. Imbrogno as Vice President and Chief Financial Officer
"Since joining PDL, Ed has made highly valued contributions as leader of our finance organization and member of our senior leadership team. He is instrumental to the execution of our monetization strategy and the distribution of net proceeds to our stockholders. I look forward to our continued partnership," said
Throughout its history, PDL's mission has been to improve the lives of patients by aiding in the successful development of innovative therapeutics and healthcare technologies.
For more information please visit www.pdl.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-announces-appointment-of-edward-a-imbrogno-as-vice-president-and-chief-financial-officer-301019974.html
Investors, Dominique Monnet, PDL BioPharma President & CEO, 775-832-8500, Dominique.Monnet@pdl.com; LHA Investor Relations, Jody Cain, SVP, 310-691-7100, email@example.com